Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis (COMBO-UC)

NCT06453317 is registered in ClinicalTrials.gov with Medical University of Lodz as lead sponsor.

NCT NCT06453317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06453317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis (COMBO-UC)
Lead sponsor
Medical University of Lodz
Phase
Phase 2
Overall status
Recruiting
Start date
February 17, 2025
Completion date
June 30, 2028
Enrollment
172 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel diseases, ulcerative colitis